222 related articles for article (PubMed ID: 31685560)
21. Differences in Baseline Characteristics and White Blood Cell Ratios Between Racial Groups in Patients with Pancreatic Adenocarcinoma.
Ueberroth BE; Khan A; Zhang KJ; Philip PA
J Gastrointest Cancer; 2021 Mar; 52(1):160-168. PubMed ID: 32077005
[TBL] [Abstract][Full Text] [Related]
22. Metformin use is associated with better survival of diabetic patients with pancreatic cancer.
Sadeghi N; Abbruzzese JL; Yeung SC; Hassan M; Li D
Clin Cancer Res; 2012 May; 18(10):2905-12. PubMed ID: 22465831
[TBL] [Abstract][Full Text] [Related]
23. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
[TBL] [Abstract][Full Text] [Related]
24. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
[TBL] [Abstract][Full Text] [Related]
25. Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes.
Egede LE; Lynch CP; Gebregziabher M; Hunt KJ; Echols C; Gilbert GE; Mauldin PD
J Gen Intern Med; 2013 Feb; 28(2):208-15. PubMed ID: 22948932
[TBL] [Abstract][Full Text] [Related]
26. The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy.
Choi Y; Kim TY; Oh DY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Cancer Res Treat; 2016 Jan; 48(1):171-9. PubMed ID: 25779362
[TBL] [Abstract][Full Text] [Related]
27. Association of Health-Care System and Survival in African American and Non-Hispanic White Patients With Bladder Cancer.
Kotha NV; Kumar A; Qiao EM; Qian AS; Voora RS; Nalawade V; Karim Kader A; McKay RR; Stewart TF; Rose BS
J Natl Cancer Inst; 2022 Apr; 114(4):600-608. PubMed ID: 34918091
[TBL] [Abstract][Full Text] [Related]
28. Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer.
Dadi N; Stanley M; Shahda S; O'Neil BH; Sehdev A
Anticancer Res; 2017 Oct; 37(10):5533-5539. PubMed ID: 28982867
[TBL] [Abstract][Full Text] [Related]
29. Body mass index does not affect the survival of pancreatic cancer patients.
Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
[TBL] [Abstract][Full Text] [Related]
30. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract][Full Text] [Related]
31. The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer.
Kleeff J; Costello E; Jackson R; Halloran C; Greenhalf W; Ghaneh P; Lamb RF; Lerch MM; Mayerle J; Palmer D; Cox T; Rawcliffe CL; Strobel O; Büchler MW; Neoptolemos JP
Br J Cancer; 2016 Sep; 115(7):887-94. PubMed ID: 27584663
[TBL] [Abstract][Full Text] [Related]
32. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
[TBL] [Abstract][Full Text] [Related]
33. Race, treatment, and survival of veterans with cancer of the distal esophagus and gastric cardia.
Dominitz JA; Maynard C; Billingsley KG; Boyko EJ
Med Care; 2002 Jan; 40(1 Suppl):I14-26. PubMed ID: 11789626
[TBL] [Abstract][Full Text] [Related]
34. Metformin and survival in pancreatic cancer: a retrospective cohort study.
Hwang AL; Haynes K; Hwang WT; Yang YX
Pancreas; 2013 Oct; 42(7):1054-9. PubMed ID: 24051965
[TBL] [Abstract][Full Text] [Related]
35. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis.
Shi YQ; Zhou XC; Du P; Yin MY; Xu L; Chen WJ; Xu CF
Medicine (Baltimore); 2020 Sep; 99(37):e21687. PubMed ID: 32925714
[TBL] [Abstract][Full Text] [Related]
36. The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis.
Jeon CY; Li D; Cleary S; Stolzenberg-Solomon R; Bosetti C; La Vecchia C; Porta M; Toriola AT; Hung RJ; Kurtz RC; Olson SH
Pancreas; 2018 Mar; 47(3):314-320. PubMed ID: 29401167
[TBL] [Abstract][Full Text] [Related]
37. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
[TBL] [Abstract][Full Text] [Related]
38. Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer.
Wu BU; Butler RK; Lustigova E; Lawrence JM; Chen W
JAMA Netw Open; 2020 Jun; 3(6):e204945. PubMed ID: 32530471
[TBL] [Abstract][Full Text] [Related]
39. Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer.
Cerullo M; Gani F; Chen SY; Canner J; Pawlik TM
J Gastrointest Surg; 2016 Sep; 20(9):1572-80. PubMed ID: 27255657
[TBL] [Abstract][Full Text] [Related]
40. The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD.
Shin JI; Sang Y; Chang AR; Dunning SC; Coresh J; Inker LA; Selvin E; Ballew SH; Grams ME
J Am Soc Nephrol; 2020 Aug; 31(8):1847-1858. PubMed ID: 32660971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
